Business Context and Reporting Period
This Form 10-Q covers The Procter & Gamble Company for the quarterly period ended September 30, 2000. The company operates globally across Fabric & Home Care, Paper, Beauty Care, Health Care, and Food & Beverage segments. The financial statements are unaudited but include all adjustments necessary for a fair presentation.
Key Financial Metrics
| Metric | Q1 2001 (Sep 30, 2000) | Q1 2000 (Sep 30, 1999) |
|---|---|---|
| Net Sales | $9,969 million | $9,919 million |
| Operating Income | $1,779 million | $1,847 million |
| Net Earnings | $1,155 million | $1,147 million |
| Diluted EPS | $0.82 | $0.80 |
| Core Net Earnings (Excl. Restructuring) | $1,240 million | N/A |
| Core EPS | $0.88 | $0.88 |
| Gross Margin | 46.8% | 47.5% |
| Operating Margin | 17.8% | 18.6% |
| Cash from Operations | $1,081 million | $1,347 million |
| Total Debt (Current + Long-Term) | $12,661 million | N/A |
| Cash and Equivalents | $2,001 million | $2,123 million |
Material Changes vs. Prior Period
- Revenue: Net sales increased 1% to $9.97 billion, driven by pricing and volume gains offset by a negative foreign exchange impact (primarily the euro). Excluding currency effects, sales grew 4%.
- Profitability: Net earnings rose slightly to $1.16 billion. However, reported margins declined due to significant commodity cost increases and restructuring charges. Core earnings (excluding restructuring) remained flat year-over-year at $0.88 per share.
- Restructuring: The company recorded $107 million in pre-tax charges related to the "Organization 2005" program, including $63 million in cost of products sold and $44 million in operating expenses.
- Segment Performance:
- Fabric & Home Care: Sales down 3% due to currency; earnings up 3%.
- Paper: Sales up 1%; earnings down 4% due to exchange rates and commodity costs.
- Beauty Care: Sales up 2%; earnings up 19% due to pricing and lower taxes.
- Health Care: Sales up 24% (driven by Iams acquisition); earnings down 11% due to prior year licensing/divestiture activity.
- Food & Beverage: Sales down 13%; earnings down 29% due to volume declines in snacks and beverages.
- Liquidity: Cash from operating activities decreased to $1.08 billion from $1.35 billion, largely due to changes in working capital (increases in receivables and inventories). Total debt increased by $535 million since June 30, 2000, primarily to fund share repurchases.
Guidance, Outlook, and Risks
- Guidance: Management confirmed prior guidance for the second quarter (Oct-Dec 2000), expecting core earnings per share growth in the mid-single-digits ($0.91 to $0.93). Sales excluding foreign exchange are expected to be up slightly, with volume down in the low-single-digits.
- Outlook: The second quarter will benefit from minor brand divestitures (e.g., Clearasil) but faces a strong year-over-year comparison base.
- Risks and Contingencies:
- Commodity Costs: Significant volatility in raw material prices continues to pressure gross margins.
- Currency: Unfavorable foreign exchange rates, particularly the euro, negatively impacted sales and earnings.
- Restructuring: Ongoing "Organization 2005" program involves manufacturing consolidations and employee separations, with costs expected to continue into fiscal 2001.
- Market Conditions: Competitive pressure in Food & Beverage and Western Europe softness in Fabric & Home Care.
Investor Verification Checklist
- Verify the sustainability of core earnings growth given the offsetting impacts of commodity costs and currency fluctuations.
- Monitor the execution and cost trajectory of the "Organization 2005" restructuring program, specifically the $107 million charge and future cash outflows.
- Assess the turnaround potential in the Food & Beverage segment, which saw double-digit declines in both volume and earnings.
- Review the impact of the Iams acquisition on the Health Care segment's long-term profitability versus the current earnings drag from prior year divestitures.
- Confirm the effectiveness of pricing strategies in maintaining gross margins amidst rising input costs.